ForViva (LON:FVA – Get Free Report)‘s stock had its “buy” rating reaffirmed by Canaccord Genuity Group in a report issued on Wednesday, Digital Look reports. They presently have a GBX 190 price objective on the stock. Canaccord Genuity Group’s price target would suggest a potential upside of 29.25% from the company’s current price.
Separately, Shore Capital Group reissued a “hold” rating and set a GBX 135 price objective on shares of ForViva in a report on Wednesday. One equities research analyst has rated the stock with a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, ForViva currently has an average rating of “Moderate Buy” and an average price target of GBX 162.50.
Get Our Latest Analysis on FVA
ForViva Trading Up 5.0%
Insider Buying and Selling at ForViva
In other news, insider Tim Jones bought 40,000 shares of the company’s stock in a transaction that occurred on Friday, July 17th. The stock was bought at an average price of GBX 138 per share, for a total transaction of £55,200. Over the last 90 days, insiders bought 90,000 shares of company stock valued at $12,380,000. Company insiders own 7.31% of the company’s stock.
ForViva Company Profile
ForViva plc (LON: FVA) is a United Kingdom–based property company that operates in the residential and specialist housing sectors. The group’s activities are focused on ownership, management and leasing of housing assets that serve social, affordable and supported living needs. Its portfolio is oriented toward providing long‑term rental accommodation and specialist premises that accommodate people requiring additional care or support.
Services associated with ForViva’s property portfolio typically include day‑to‑day asset management, tenancy management, property maintenance and refurbishment, and collaboration with public sector bodies and third‑party care providers to deliver supported housing solutions.
Featured Articles
- Five stocks we like better than ForViva
- O’Reilly Automotive’s Stock Slump Hides a Stronger Business
- McDonald’s Stock Slump Makes Its AI Pricing Bet Even Riskier
- Broadcom’s AI Growth Story Faces a $161 Billion Anthropic Test
- 3 Emerging Biotech Stocks With Significant Upside Potential
Receive News & Ratings for ForViva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ForViva and related companies with MarketBeat.com's FREE daily email newsletter.
